Positioning political buying, disclosed 2026-09-25
Options put/call open interest 1.02, read 2026-10-24
Ethical does not pass the values gate
Price313.61 USD
Fair value356.86
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-20Read Markup308.64+1.6% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution301.81+3.9% to today Markup gives way to Distribution after a 14% slide in 5 weeks
2026-08-27Read Markup349.01-10.1% to today Distribution gives way to Markup after an 11% rise in 8 weeks
2026-07-02Read Distribution313.99-0.1% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Domino's holds its Markup at $313.61. The statistical read favours the sellers, held for 515 days.
As held on the ledger · 2026-10-23
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 515 days
Price at the screen
$313.61
Valuation
17.00 trailing · 14.95 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.95
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
294.11%
Below 33%
Interest-bearing debt is 294.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
2.10%
Below 33%
Cash held in interest-bearing accounts and securities is 2.1% of assets, under the one-third limit.
Pass
Receivables
25.73%
Below 49%
Money owed to the company is 25.7% of assets, under the 49% limit.
Pass
Revenue purity
0.30%
Below 5%
Only 0.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Domino's's business is in a permissible area, but its interest-bearing debt is about 294% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DPZ's ethical verdict changes
Today DPZ does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · Consumer boycott campaigns
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited in consumer boycott campaigns for franchise pizza delivery operations in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 16% discount to our $356.86 fair value, 3.40% revenue growth.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 15.6% margin of safety to the base estimate.
Third-party analyst targets: 27 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Pizza deliveries cannot hide the debt load
Picture a late night order landing at the door. The franchised network behind it carries too much debt, so Domino's fails our ethical screen and we pass, even with shares below our fair value estimate.
Revenue edges ahead at 4 percent while margins sit at 12 percent and the forward multiple is 15.5 times earnings. Analysts see further upside yet the debt ratio rules the name out for us.
That leverage leaves the business exposed if consumer spending slows in this cyclical sector, turning modest growth into a cash strain. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DPZ trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Markup$308.64+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
2026-10-20Markup · changed$308.64-0.2%Entry 11
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
2026-10-13Distribution$309.36+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-12Distribution$309.36+2.5%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Distribution$301.81+0.0%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-10Distribution$301.81+0.0%Entry 7
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 13.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
2026-08-27Markup · changed$349.01+8.3%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
2026-07-26Distribution$322.18+2.6%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
2026-07-18Distribution$313.99+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (30 analysts) rates it buy, with a mean price target of $406.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
